97 related articles for article (PubMed ID: 27486758)
1. Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy.
Sun W; Li G; Wan J; Zhu J; Shen W; Zhang Z
Oncotarget; 2016 Oct; 7(43):69507-69517. PubMed ID: 27486758
[TBL] [Abstract][Full Text] [Related]
2. The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
Rampazzo E; Del Bianco P; Bertorelle R; Boso C; Perin A; Spiro G; Bergamo F; Belluco C; Buonadonna A; Palazzari E; Lonardi S; De Paoli A; Pucciarelli S; De Rossi A
Br J Cancer; 2018 Mar; 118(6):878-886. PubMed ID: 29449673
[TBL] [Abstract][Full Text] [Related]
3. The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
De Palma FDE; Luglio G; Tropeano FP; Pagano G; D'Armiento M; Kroemer G; Maiuri MC; De Palma GD
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987896
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Depression, Anxiety, and Sexual Function in Rectal Cancer Patients Before and After Neoadjuvant Chemoradiotherapy.
Dağdelen M; Çatal TK; Demirel ÖF; Ürün E; Kaçar S; Çepni K; Can G; Öksüz DÇ; Duran A
J Gastrointest Cancer; 2023 Dec; 54(4):1347-1352. PubMed ID: 37280447
[TBL] [Abstract][Full Text] [Related]
5. T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancer.
Akiyoshi T; Gotoh O; Tanaka N; Kiyotani K; Yamamoto N; Ueno M; Fukunaga Y; Mori S
Cancer Immunol Immunother; 2021 Feb; 70(2):509-518. PubMed ID: 32845355
[TBL] [Abstract][Full Text] [Related]
6. CD11c
Tse BCY; Bergamin S; Steffen P; Hruby G; Pavlakis N; Clarke SJ; Evans J; Engel A; Kneebone A; Molloy MP
Oncoimmunology; 2023; 12(1):2238506. PubMed ID: 37485033
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Tissue and Circulating miR-21 as Potential Biomarker of Response to Chemoradiotherapy in Rectal Cancer.
Ourô S; Mourato C; Ferreira MP; Albergaria D; Cardador A; Castro RE; Maio R; Rodrigues CMP
Pharmaceuticals (Basel); 2020 Sep; 13(9):. PubMed ID: 32937907
[TBL] [Abstract][Full Text] [Related]
8. The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.
Kölbl AC; Jeschke U; Andergassen U
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529216
[TBL] [Abstract][Full Text] [Related]
9. The Crying Need for a Better Response Assessment in Rectal Cancer.
Amintas S; Giraud N; Fernandez B; Dupin C; Denost Q; Garant A; Frulio N; Smith D; Rullier A; Rullier E; Vuong T; Dabernat S; Vendrely V
Curr Treat Options Oncol; 2023 Nov; 24(11):1507-1523. PubMed ID: 37702885
[TBL] [Abstract][Full Text] [Related]
10. Circulating Tumour Cell Associated MicroRNA Profiles Change during Chemoradiation and Are Predictive of Response in Locally Advanced Rectal Cancer.
Lim SH; Chua W; Ng W; Ip E; Marques TM; Tran NT; Gama-Carvalho M; Asghari R; Henderson C; Ma Y; de Souza P; Spring KJ
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627212
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy.
Yin TC; Chen PJ; Yeh YS; Li CC; Chen YC; Su WC; Chang TK; Huang CW; Huang CM; Tsai HL; Wang JY
Front Oncol; 2023; 13():1099168. PubMed ID: 37064097
[TBL] [Abstract][Full Text] [Related]
12. Metastasis risk stratification and response prediction through dynamic viable circulating tumor cell counts for rectal cancer in a neoadjuvant setting.
Liu WY; Zhang W; Tang Y; Chen SL; Li N; Lei JQ; Shi JM; Wang SL; Li YX; Zhang KT; Jin J
Cancer Med; 2023 May; 12(10):11438-11450. PubMed ID: 37014817
[TBL] [Abstract][Full Text] [Related]
13. A Review of Circulating Tumor DNA as a Biomarker Guide for Total Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer.
Yahya J; Baber M; Nabavizadeh N; Goodyear SM; Kardosh A
J Gastrointest Cancer; 2023 Dec; 54(4):1140-1150. PubMed ID: 36719559
[TBL] [Abstract][Full Text] [Related]
14. Clinical Utility of Circulating Tumor Cells for Predicting Major Histopathological Response after Neoadjuvant Chemoradiotherapy in Patients with Esophageal Cancer.
Gao X; Leow OQ; Chiu CH; Hou MM; Hsieh JC; Chao YK
J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143225
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
Lee HH; Chen CH; Huang YH; Chiang CH; Huang MY
Cells; 2022 May; 11(10):. PubMed ID: 35626648
[TBL] [Abstract][Full Text] [Related]
16. PRL-3 and MMP9 Expression and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells From Patients With Colorectal Cancer: Potential Value in Clinical Practice.
Hong XC; Liang QL; Chen M; Yang HX; Huang J; Yi SL; Wang ZW; Liang HY; Zhang DY; Huang ZY
Front Oncol; 2022; 12():878639. PubMed ID: 35574414
[TBL] [Abstract][Full Text] [Related]
17. Perioperative Circulating Tumor Cells (CTCs), MCTCs, and CTC-White Blood Cells Detected by a Size-Based Platform Predict Prognosis in Renal Cell Carcinoma.
Wang Z; Zhang P; Chong Y; Xue Y; Yang X; Li H; Wang L; Zhang Y; Chen Q; Li Z; Xue L; Li H; Chong T
Dis Markers; 2021; 2021():9956142. PubMed ID: 34733376
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of circulating epithelial tumor cells using the Maintrac
Gold M; Pachmann K; Kiani A; Schobert R
Mol Clin Oncol; 2021 Oct; 15(4):201. PubMed ID: 34462657
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients.
Alkan A; Hofving T; Angenete E; Yrlid U
Biomark Res; 2021 Jul; 9(1):60. PubMed ID: 34321074
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer.
Silva VSE; Abdallah EA; Flores BCT; Braun AC; Costa DJF; Ruano APC; Gasparini VA; Silva MLG; Mendes GG; Claro LCL; Calsavara VF; Aguiar Junior S; de Mello CAL; Chinen LTD
Cells; 2021 Jun; 10(6):. PubMed ID: 34207124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
